Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease by Fabrizio Tomai, Flavio Ribichini, Anna S. Ghini, Valeria Ferrero, Giuseppe Andò, Corrado Vassanelli, Francesco Romeo, Filippo Crea, and Luigi Chiariello EHJ Volume 26(20): September 29, 2005 © The European Society of Cardiology All rights reserved. For Permissions, please
Figure 1 Per cent changes from baseline of CBF in response to substance P infusion. Fabrizio Tomai et al. Eur Heart J 2005;26: © The European Society of Cardiology All rights reserved. For Permissions, please
Figure 2 Per cent changes from baseline of CBF in response to adenosine infusion. Fabrizio Tomai et al. Eur Heart J 2005;26: © The European Society of Cardiology All rights reserved. For Permissions, please
Figure 3 Relation between per cent changes from baseline of CBF in response to the peak dose of substance P and logarithmically transformed C-reactive protein levels (log-C-reactive protein). Fabrizio Tomai et al. Eur Heart J 2005;26: © The European Society of Cardiology All rights reserved. For Permissions, please
Figure 4 Relation between per cent changes from baseline of CBF in response to adenosine and logarithmically transformed C-reactive protein levels (log-C-reactive protein). Fabrizio Tomai et al. Eur Heart J 2005;26: © The European Society of Cardiology All rights reserved. For Permissions, please